Minimally invasive direct coronary artery bypass surgery
Minimally Invasive Direct Coronary Artery Bypass Surgery (MIDCAB) is a type of heart surgery that involves bypassing blocked coronary arteries to improve blood flow to the heart. This procedure is considered "minimally invasive" because it is performed through a small incision in the chest, rather than the traditional open-heart surgery approach.
Procedure[edit | edit source]
The MIDCAB procedure is performed under general anesthesia. The surgeon makes a small incision on the left side of the chest to access the heart. Using a special retractor, the surgeon lifts the rib cage to expose the heart. The blocked coronary artery is then bypassed using a graft taken from the patient's own body, typically the internal mammary artery or a vein from the leg. The graft is attached to the coronary artery above and below the blockage, effectively creating a new route for blood to flow to the heart.
Benefits[edit | edit source]
MIDCAB surgery offers several benefits over traditional open-heart surgery. These include a smaller incision, less pain, reduced risk of infection, shorter hospital stay, quicker recovery, and less scarring. However, it may not be suitable for all patients, particularly those with multiple blocked coronary arteries.
Risks[edit | edit source]
As with any surgical procedure, MIDCAB surgery carries some risks. These may include bleeding, infection, stroke, heart attack, irregular heart rhythms, and complications from anesthesia. The risk of complications is generally low, but can be influenced by the patient's overall health and the skill and experience of the surgical team.
Recovery[edit | edit source]
Recovery from MIDCAB surgery is typically quicker than from traditional open-heart surgery. Most patients can expect to stay in the hospital for a few days following the procedure. Full recovery can take several weeks, during which time patients are advised to avoid strenuous activity and follow a heart-healthy diet.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD